QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully ...
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the formation of a malignant tumor. Subscribe to our newsletter for the latest ...
A new method vastly improves on the existing approach for single-cell genetic sequencing, enabling scientists to read the genomes of individual cells and viral particles in the environment more ...
Learn how moving beyond ELISA can streamline your cell line development and boost productivity without compromising results.
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...
New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.
The acquisition, which enables Qiagen to enter the single-cell sequencing market, is expected to close in December and contribute $40 million to 2026 revenues.
A pioneering method enables simultaneous RNA and metabolite analysis in the same cell, revealing the molecular choreography underlying the biosynthesis of medically relevant natural products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback